To read more on this topic click here.
Genetic database gives hope for potential Parkinson’s treatment
Author: Saskia MairPublished: 4 June 2020
Prep: Cook: Serves:
The Genome Aggregation Database (gnomAD) – the world’s largest public database of variations in DNA which can cause diseases – has given scientists hope for a potential Parkinson’s treatment.
UK and US researchers from Imperial College London, the Broad Institute of MIT and Harvard, 23andMe and the Michael J. Fox Foundation used gnomAD to study variants in the LRRK2 gene, which increases the risk of Parkinson’s. Previous studies have shown that blocking the protein formed by the gene can lead to organ damage in animals – but the scientists now suggest this approach should be safe for humans.
Research fellow Dr Nicky Whiffin said: “Large genetic databases are increasingly giving us a powerful insight into the likely impact of certain drugs. If we see that genetic variants that naturally reduce the amount of protein in our body do not result in severe diseases, we can be more confident that targeting that protein therapeutically will also be safe.”
For more information on the latest Parkinson’s research please visit the Parkinson’s Europe website.
Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests
Can Covid-19 increase the risk of developing Parkinson’s?
Share this story
PD in Practice
WEBINAR: Get expert advice on managing Parkinson’s pain and fatigue
Join this free MJ Fox Foundation live webinarREAD MORE
Pro cyclist to non-profit founder: Davis Phinney on life with Parkinson’s
The Tour de France stage winner talks about living well with Parkinson’sREAD MORE
Parkinson’s in the news: November
This month’s top Parkinson’s disease news stories from around the globeREAD MORE